Endologix's CEO Presents At The 2012 Bank Of America Merrill Lynch Health Care Conference (Transcript)

Endologix Inc (ELGX)

2012 Bank of America Merrill Lynch Health Care Conference

May 16, 2012 6:00 PM EST

Executives

John D. McDermott – President & CEO

Presentation

Moderator

Endologix. I’m pleased to introduce to you John McDermott, President and CEO. We’ll have a brief presentation and we’ll go to Q&A thereafter. Thanks.

John D. McDermott

Okay, thank you. Good afternoon everybody. Those are Safe Harbor Statements. So this is going to be quick. I am going to give you a very accelerated version of the company. I can talk all afternoon about it, but I’ll give you a quick overview and then we’ll open it up for Q&A as he mentioned.

Just briefly, the company is well positioned for ultimately a leadership position in a large and growing market. A lot of growth drivers, very deep new product portfolio as well as a strong core business. We’ve been expanding our sale force in the United States and now we are embarking on an effort to go direct in Europe, as well as we’ve been putting up some pretty good numbers along the way as you can see here. Good gross margins and good anticipated continued growth.

So this is what we do. We repair Aneurisms and we do that through catheter-based therapy. Years and years ago if you had an Abdominal Aortic Aneurism, there was really one way to fix it and that was through an open incision from above the bottom of your Sternum, down below your belly button, what we call Open Surgical Repair.

If you liked this article you might like

Endologix Poised for a Potentially Volatile Breakout

5 Stocks Trending Close to Major Breakouts

5 Stocks Set for Explosive Breakouts

These 5 Stocks Under $10 Could Make You a Lot of Money

Week in Review: Trump Rally Fizzles but Stocks End 2016 With Big Gains